✦ LIBER ✦

Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients

✍ Scribed by Hildegunn Berntsen; Per Eystein Lønning; Dagfinn Ekse; Bjørn Netteland; Dag Clement Johannessen; Rolf Berge; Asbjørn Svardal

Publisher: Springer
Year: 1998
Tongue: English
Weight: 454 KB
Volume: 42
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050783

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of aminoglutethimide on plasma

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment

✍ P. E. Lønning; M. Dowsett; A. Jones; D. Ekse; S. Jacobs; F. McNeil; D. C. Johann 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 643 KB

A study of glutathione status in the blo

A study of glutathione status in the blood and tissues of patients with breast cancer

✍ Chih-Ching Yeh; Ming-Feng Hou; Szu-Hsien Wu; Shih-Meng Tsai; Shu-Kai Lin; Linda 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 3 views

Influence of aminoglutethimide on the me

Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer

✍ S. Lundgren; P. E. Lønning; A. Aakvaag; S. Kvinnsland 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 496 KB

Influence of age and comorbidity on trea

Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer

✍ Liesbeth Bergman; Gert Dekker; Elly HM van Kerkhoff; Hans L. Peterse; Johannes A 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 733 KB

The relationship of urinary and plasma a

The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survial

✍ Barbara H. Mason; Ian M. Holdaway; Stephen J. M. Skinner; Ronald G. Kay 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 702 KB

Influence of treatment with tamoxifen an

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

✍ Svein I. Helle; Jeff M. P. Holly; Michael Tally; Kerstin Hall; Jos Van Der Stapp 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 540 KB

Plasma levels of IGF-I, IGFBP-I and IGFBP-3 were measured before and during treatment with tamoxifen up to 19+ months in 34 post-menopausal patients with advanced breast cancer. In 28 patients, pro-IGF-IIE (IGF-IIE) levels were determined and IGFBP-3 was evaluated by immunoblot in 27 patients. Tamox